Diane Hagerty is the Senior Vice President of Quality at Allogene overseeing GxP quality and compliance activities across R&D and Operations Technology. Before she joined Allogene, she served as the Vice President, Head of GxP Quality & Compliance at MyoKardia. She previously served in a variety of executive Quality roles at Dermira, Ultragenyx, Genentech/Roche, and Johnson & Johnson spanning bio/pharmaceuticals, medical devices, and information technology. She began her working career at SmithKline Beecham Pharmaceuticals, holding roles of increasing responsibility in Research & Development and Regulatory Affairs. She holds a B.S. in Biology from Bates College and a Master of Science in Pharmaceutical Quality Assurance and Regulatory Affairs from Temple University.
Current role